Publication | Open Access
Overexpression of the Pluripotent Stem Cell Marker Podocalyxin in Prostate Cancer
20
Citations
23
References
2018
Year
Overexpression of podocalyxin in prostate cancer renders the protein a putative immunohistochemical marker of prostate cancer that may contribute to stratification of patients for optimal treatment.
| Year | Citations | |
|---|---|---|
Page 1
Page 1